| Health Care Equipment & Supplies Industry | Healthcare Sector | Dr. Zhaohua Chang Ph.D. CEO | HKEX Exchange | - ISIN |
| China Country | 6,287 Employees | - Last Dividend | - Last Split | - IPO Date |
MicroPort Scientific Corporation is a pioneering force in the medical device industry, specializing in the research, development, manufacture, and distribution of a wide range of medical devices globally. The company's footprint extends from its headquarters in Shanghai, China, across major regions including North America, Europe, South America, the People's Republic of China, and other Asian countries. As an investment holding company founded in 1998, MicroPort Scientific Corporation stands at the forefront of medical innovation, providing comprehensive solutions across various healthcare sectors such as cardiovascular, orthopedics, cardiac rhythm management, endovascular, and neurovascular diseases, as well as in new technological areas like surgical robotics and surgical devices. Through its extensive product portfolio and commitment to research and development, the company aims to significantly improve the quality of life for patients around the world while pushing the boundaries of medical technology.
MicroPort offers a broad range of solutions for the treatment of coronary artery diseases, including coronary stents, delivery systems, balloon catheters, and accessories, aiming to improve patient outcomes in cardiovascular care.
The company's orthopedics division provides comprehensive solutions for reconstructive joints, spine and trauma products, and professional instruments, supporting patients in regaining mobility and quality of life.
With cutting-edge technology, MicroPort delivers critical solutions like defibrillators, cardiac resynchronization therapy devices, and pacemakers for managing heart rhythm disorders and heart failure, enhancing patient care in cardiac rhythm management.
This segment addresses the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, and other related conditions, with a focus on advancing endovascular therapy.
MicroPort's neurovascular segment is dedicated to providing therapeutic and access devices for neurovascular diseases, aiming to offer effective treatments for conditions such as strokes and aneurysms.
Offering innovative products like the VitaFlow Transcatheter aortic valve and its delivery system, along with a range of surgical valve products, this division focuses on pioneering solutions in heart valve replacement and repair.
The company is also breaking new ground in medical tech with its development and commercialization of surgical robots, enhancing precision in surgical procedures through advanced robotics and control algorithms.
Through ongoing research and development, MicroPort manufactures and sells an array of surgical devices designed to facilitate various medical procedures, underlining the company’s commitment to innovation in surgical interventions.